Antaros Medical AB:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Antaros Medical AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10990
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Antaros Medical AB (Antaros Medical) is a drug development and technology company that offers innovative MRI and PET imaging techniques for decision making in clinical drug development. The company’s services include small- to medium-sized studies, decision-making in Phase 1b and Phase 2 trials, pre-clinical services, regulatory approval, and life cycle management services. It also provides imaging endpoints and expert support for product differentiation in life cycle management services. Antaros Medical’s imaging endpoints comprise insulin resistance, B-cell mass and function, body composition, atherosclerosis measurement, and assessment of coronary atherosclerosis. The company’s targeted therapeutic areas include cardio-metabolic, inflammatory, respiratory, and neuroscience diseases. It has its operations in Uppsala and Gothenburg, Sweden. Antaros Medical is headquartered in Uppsala, Sweden.

Antaros Medical AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Antaros Medical AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Antaros Medical AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Antaros Medical AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Antaros Medical AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Antaros Medical AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Antaros Medical AB, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Athera Biotech Raises USD7.2 Million in Venture Financing 10
Emeriti Pharma Raises USD0.3 Million in Venture Financing 12
Athera Biotechnologies Raises USD2.8 Million in Venture Financing 13
Acquisition 14
Ostersjostiftelsen Consortium to Acquire Stake in Athera Biotechnologies from Karolinska Development 14
Antaros Medical AB – Key Competitors 16
Antaros Medical AB – Key Employees 17
Antaros Medical AB – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Government and Public Interest 19
Nov 21, 2017: Antaros partner in ground-breaking European project concerning biomarkers for liver disease 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Antaros Medical AB, Pharmaceuticals & Healthcare, Key Facts 2
Antaros Medical AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Antaros Medical AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Antaros Medical AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Antaros Medical AB, Deals By Therapy Area, 2012 to YTD 2018 8
Antaros Medical AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Athera Biotech Raises USD7.2 Million in Venture Financing 10
Emeriti Pharma Raises USD0.3 Million in Venture Financing 12
Athera Biotechnologies Raises USD2.8 Million in Venture Financing 13
Ostersjostiftelsen Consortium to Acquire Stake in Athera Biotechnologies from Karolinska Development 14
Antaros Medical AB, Key Competitors 16
Antaros Medical AB, Key Employees 17
Antaros Medical AB, Other Locations 18

List of Figures
Antaros Medical AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Antaros Medical AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Antaros Medical AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Antaros Medical AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Antaros Medical AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Antaros Medical AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Antaros Medical AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Antaros Medical AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Antaros Medical AB:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • De’Longhi S.p.A. (DLG):企業の財務・戦略的SWOT分析
    De'Longhi S.p.A. (DLG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Praxair Inc (PX):石油・ガス:M&Aディール及び事業提携情報
    Summary Praxair Inc (Praxair) is a producer and supplier of industrial gases. The company produces atmospheric gases including oxygen, nitrogen, argon and rare gases, and process gases such as carbon dioxide, helium, hydrogen, electronic gases, specialty gases and acetylene. It also designs and buil …
  • IBC Solar AG:企業の戦略的SWOT分析
    IBC Solar AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Punjab National Bank (PNB):企業の財務・戦略的SWOT分析
    Punjab National Bank (PNB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Span Diagnostics Ltd (524727)-医療機器分野:企業M&A・提携分析
    Summary Span Diagnostics Ltd (SPAN) is a medical equipment company that develops and manufactures diagnostic products for healthcare markets. The company’s products include reagents, antibiotic disc and instruments. It offers reagents such as glucose, microprotein, amylase, calcium, chloride, uric a …
  • Sainsbury’s Bank plc:企業の戦略・SWOT・財務情報
    Sainsbury's Bank plc - Strategy, SWOT and Corporate Finance Report Summary Sainsbury's Bank plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Keane Group Inc (FRAC):石油・ガス:M&Aディール及び事業提携情報
    Summary Keane Group Inc (Keane Group) is an oil and gas company that offers integrated completion and drilling services. The company provides hydraulic fracturing services, engineered solutions, wire-line services, pressure pumping, cementing service, coiled tubing and well intervention services. It …
  • Damac Real Estate Development Ltd:企業の戦略・SWOT・財務分析
    Damac Real Estate Development Ltd - Strategy, SWOT and Corporate Finance Report Summary Damac Real Estate Development Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • ReNeuron Group Plc (RENE):企業の財務・戦略的SWOT分析
    ReNeuron Group Plc (RENE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Hitachi Zosen Corporation (7004)-エネルギー分野:企業M&A・提携分析
    Summary Hitachi Zosen Corporation (Hitachi Zosen) is an industrial and engineering company that manufactures heavy industrial machinery. It conducts design and construction of process equipment, environmental systems, industrial plants, infrastructure-related equipment, disaster prevention systems, …
  • Dongbu Corporation:企業の戦略・SWOT・財務情報
    Dongbu Corporation - Strategy, SWOT and Corporate Finance Report Summary Dongbu Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • RegeneRx Biopharmaceuticals Inc (RGRX):企業の財務・戦略的SWOT分析
    Summary RegeneRx Biopharmaceuticals Inc (RegeneRx) is a clinical-stage biopharmaceutical company that designs, researches and develops novel peptides targeted at diseases with unmet medical needs. The company offers clinical trials, science and discovery and business development services. Its busine …
  • Netmedia S.A.
    Netmedia S.A. - Strategy, SWOT and Corporate Finance Report Summary Netmedia S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Team Health Holdings Inc-製薬・医療分野:企業M&A・提携分析
    Summary Team Health Holdings Inc (TeamHealth) is a healthcare organization that offers patient care services. The organization’s practice areas include emergency medicine, anesthesiology, hospital medicine, hospital medicine subspecialties, ambulatory care, post-acute care and behavioral health serv …
  • Spherix Inc (SPEX):企業の財務・戦略的SWOT分析
    Spherix Inc (SPEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Petrolympic Ltd (PCQ):石油・ガス:M&Aディール及び事業提携情報
    Summary Petrolympic Ltd (Petrolympic) is an oil and gas exploration and development company that acquires, explores and develops light crude oil and natural gas in North America. The company holds interests in conventional natural gas and light oil projects in Gaspe Peninsula of Quebec. It holds int …
  • Applied Materials Inc (AMAT):企業の財務・戦略的SWOT分析
    Applied Materials Inc (AMAT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Kolon Life Science Inc (102940)-製薬・医療分野:企業M&A・提携分析
    Summary Kolon Life Science Inc (KLS) carries out research and development, manufacture and commercialization of pharmaceutical products and active pharmaceutical ingredients (APIs). It develops innovative cell and gene therapeutics. The company's lead product is Invossa, first cell-mediated gene the …
  • Hitachi Construction Machinery Co., Ltd. (6305):企業の財務・戦略的SWOT分析
    Hitachi Construction Machinery Co., Ltd. (6305) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • The Andersons Inc (ANDE):企業の財務・戦略的SWOT分析
    The Andersons Inc (ANDE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆